India Antihyperlipidemic Drugs Market Size, Share 2025

India Antihyperlipidemic Drugs Market Size, Share, Trends and Forecast by Drug Class, Route of Administration, Distribution Channel, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A29806

Buy Now Discount
Offer

India Antihyperlipidemic Drugs Market Size and Share:

The India antihyperlipidemic drugs market size reached USD 428.19 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 607.34 Million by 2033, exhibiting a growth rate (CAGR) of 3.96% during 2025-2033. The India antihyperlipidemic drugs market share is expanding, driven by the rising aging population, which requires effective treatment to manage lipid levels, along with the increasing availability of modern diagnostic tools that enable faster and more accurate cholesterol screening.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 428.19 Million
Market Forecast in 2033	USD 607.34 Million
Market Growth Rate (2025-2033)	3.96%

India Antihyperlipidemic Drugs Market Trends:

Growing aging population

The rising geriatric population is offering a favorable India antihyperlipidemic drugs market outlook. The United Nations Population Fund (UNFPA) anticipated that the elderly population in India will reach 158 Million individuals by 2025. By the year 2050, the senior demographic is set to increase to 319 Million, equating to 19.5% of the overall population. As individuals grow older, their bodies become less effective at managing cholesterol levels, resulting in an increased risk of conditions such as hyperlipidemia. The senior population is also more susceptible to inactive lifestyles, unhealthy eating patterns, and decreased physical activity, all of which leads to high lipid levels. The elderly population needs efficient care to control cholesterol levels and reduce the likelihood of heart attacks, strokes, and various complications. Consequently, the requirement for antihyperlipidemic medications like statins, fibrates, and cholesterol absorption blockers is increasing. Moreover, healthcare professionals emphasize preventive care for older adults, promoting routine cholesterol checks and timely treatment. Enhanced access to medications enables elderly patients to control their cholesterol levels more effectively, thereby fueling the market growth. With the growth of India's elderly population, the demand for efficient lipid-lowering treatments is high.

India Antihyperlipidemic Drugs Market Size

Expanding healthcare infrastructure

The expanding healthcare infrastructure is impelling the India antihyperlipidemic drugs market growth. As hospitals, clinics, and diagnostic centers broaden across urban and rural areas, more people undergo regular health check-ups, leading to early detection of high cholesterol and related conditions. With improved facilities, healthcare providers can better manage cardiovascular risks by prescribing antihyperlipidemic drugs, such as cholesterol absorption inhibitors, statins, and fibrates. The availability of modern diagnostic tools enables faster and more accurate cholesterol screening, offering timely intervention. Additionally, telemedicine platforms and digital health services make consultations and medication management more convenient, especially in remote regions. Expanding pharmacy networks further ensure widespread access to lipid-lowering drugs, improving patient adherence to treatment. Government initiatives supporting affordable healthcare services, advanced infrastructure, and insurance coverage also encourage more individuals to seek medical support for cholesterol management. The Government of India designated INR 90,958 Crore in the FY2024-25 budget for the nation's healthcare sector, reflecting a 2% increase from INR 89,155 Crore in FY2023-24. Out of which, approximately INR 87,656 Crore was assigned to the Department of Health and Family Welfare to enhance healthcare infrastructure and to reinforce the execution of centrally sponsored schemes. As healthcare infrastructure is broadening, better access to medical advice, screening, and treatment are catalyzing the demand for antihyperlipidemic medications in India.

India Antihyperlipidemic Drugs Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on drug class, route of administration, and distribution channel.

Drug Class Insights:

Statins
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
Fibric Acid Derivatives
PCSK9 Inhibitors
Combination
Others

The report has provided a detailed breakup and analysis of the market based on the drug classes. This includes statins, bile acid sequestrants, cholesterol absorption inhibitors, fibric acid derivatives, PCSK9 inhibitors, combination, and others.

Route of Administration Insights:

Oral
Intravenous

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral and intravenous.

Distribution Channel Insights:

Hospital Pharmacies
Retail Stores
Online Retailers

The report has provided a detailed breakup and analysis of the market based on the distribution channels. This includes hospital pharmacies, retail stores, and online retailers.

Regional Insights:

North India
South India
East India
West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Antihyperlipidemic Drugs Market News:

In July 2024, the Cardiological Society of India (CSI) introduced groundbreaking guidelines for managing dyslipidemia. Dr. S. Ramakrishnan, a Cardiology professor at AIIMS in New Delhi, emphasized treatment methods that included statins, non-statin medications, and injectable lipid-lowering therapies like PCSK9 inhibitors or Inclisiran. The goal was to enable healthcare providers in India to control cholesterol levels efficiently, fight heart disease, and enhance overall health.
In January 2024, Novartis India, a well-known pharmaceutical company, revealed plans to introduce ‘Inclisiran’, a drug utilized to treat primary hypercholesterolemia or mixed dyslipidemia, in India. It could lower blood lipids and aimed to significantly decrease levels of bad cholesterol, called low-density lipoprotein cholesterol (LDL-C), in the bloodstream.

India Antihyperlipidemic Drugs Market Report Coverage:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Million USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Drug Class Route of Administration Distribution Channel Region
Drug Classes Covered	Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, Others
Routes of Administration Covered	Oral, Intravenous
Distribution Channels Covered	Hospital Pharmacies, Retail Stores, Online Retailers
Regions Covered	North India, South India, East India, West India
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the India antihyperlipidemic drugs market performed so far and how will it perform in the coming years?
What is the breakup of the India antihyperlipidemic drugs market on the basis of drug class?
What is the breakup of the India antihyperlipidemic drugs market on the basis of route of administration?
What is the breakup of the India antihyperlipidemic drugs market on the basis of distribution channel?
What are the various stages in the value chain of the India antihyperlipidemic drugs market?
What are the key driving factors and challenges in the India antihyperlipidemic drugs market?
What is the structure of the India antihyperlipidemic drugs market and who are the key players?
What is the degree of competition in the India antihyperlipidemic drugs market?

Key Benefits for Stakeholders:

IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India antihyperlipidemic drugs market from 2019-2033.
The research report provides the latest information on the market drivers, challenges, and opportunities in the India antihyperlipidemic drugs market.
Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India antihyperlipidemic drugs industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.